At the massive industry event, SupplySide, at the end of last year in Las Vegas, Nevada, the company behind the powerhouse adaptogen KSM-66 Ashwagandha, made a significant announcement that is going to have a big impact on the health and nutrition industry. Ixoreal revealed that sometime this year, next year, at the time of sharing, it would be expanding beyond its currently one and only product, and introducing an equally efficacious ingredient.
We’ve got a bit of an update on what’s happening with the KSM-66 Ashwagandha maker, Ixoreal, and its promising, highly anticipated innovation, which is having everything shared for the first time in the next few months. That will give supplement companies plenty of time to get their hands on the ingredient, brainstorm a supplement around it, and bring it to market before the end of the year, potentially even in time for this year’s edition of SupplySide.
Ixoreal will have similar control over the high-quality production and extraction of its second-ever innovation, and is currently referring to it as a women’s specific alternative to KSM-66 Ashwagandha. It is known to support hormone balance, reproductive health, menopausal symptoms, digestion, immunity, emotional stress, and more. The brand will have a stack of studies for when the ingredient comes to market, and again, it will make an impact.
Again, more information on Ixoreal’s next innovation will be along shortly and brand’s are going to want to be prepared to make use of it with how versatile and comprehensive it will be. Knowing what it can do and how successful KSM-66 Ashwagandha has been, we can see this having just as much impact and likely even start a wave of supplements centered around its benefits.
